1.
AC Rawstron, G Laycock-Brown, G Hale, FE Davies, GJ Morgan, JA Child, P Hillmen, RG Owen. CD52 expression patterns in myeloma and the applicability of alemtuzumab therapy. haematol [Internet]. 2006Nov.1 [cited 2024Nov.22];91(11):1577-8. Available from: https://haematologica.org/article/view/4226